Fig 2.
(A) Overall survival and (B) for recurrence-free survival for E1694 patients by S100B trend (normal, high, or changing from normal to high at later time points).
(A) Overall survival and (B) for recurrence-free survival for E1694 patients by S100B trend (normal, high, or changing from normal to high at later time points).